Medrio
Private Company
Funding information not available
Overview
Medrio is a private, revenue-generating software company operating in the digital health and clinical trials sector. It provides an integrated, no-code eClinical platform that aims to bridge the gap between overly complex enterprise systems and limited lightweight solutions. The company's value proposition centers on delivering validated, audit-ready technology combined with expert services to enable faster, more efficient clinical research for organizations of all sizes. With a reported 20+ years of industry experience embedded in its platform, Medrio supports thousands of studies globally and emphasizes strong customer retention and support.
Technology Platform
Integrated, no-code eClinical platform featuring EDC/CDMS, ePRO/eCOA, eConsent, and RTSM modules. Built on a cloud-native architecture with robust APIs for device, lab, and analytics system integration, designed for configurability and scalability across all trial phases.
Opportunities
Risk Factors
Competitive Landscape
Competes against large enterprise eClinical suites (e.g., Medidata Rave, Veeva Vault EDC), EDC offerings from major CROs (IQVIA, Parexel), and other focused technology providers. Differentiates by targeting the mid-market with a no-code, user-configurable platform combined with high-touch expert services, positioning itself between overly complex and overly simplistic solutions.